Insights
Innovent’s tie-up with Takeda tests investor faith in China’s biotech dream
Despite its record scale, the deal’s co-co model highlights both rising ambition and lingering skepticism in a cooling market.
Insights
Despite its record scale, the deal’s co-co model highlights both rising ambition and lingering skepticism in a cooling market.